Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116838) titled 'A study comparing the effectiveness of cariprazine and aripiprazole in people with schizophrenia' on Sept. 1.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Random Number Table Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Investigator Blinded
Primary Sponsor: Dr Amit Tripathi
Condition:
Health Condition 1: F209- Schizophrenia, unspecified
Intervention:
Intervention1: Cariprazine: We will start the drug with 1 and a half mg and to be incre...